rs1154314
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001962.3(EFNA5):c.126-73124G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000177 in 152,136 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.00018   (  0   hom.,  cov: 32) 
Consequence
 EFNA5
NM_001962.3 intron
NM_001962.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.476  
Publications
0 publications found 
Genes affected
 EFNA5  (HGNC:3225):  (ephrin A5) Ephrin-A5, a member of the ephrin gene family, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, particularly in the nervous system. EPH receptors typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin ligands and receptors have been named by the Eph Nomenclature Committee (1997). Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are similarly divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. [provided by RefSeq, Jul 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79). 
BS2
High AC in GnomAd4 at 27 AD gene. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| EFNA5 | NM_001962.3 | c.126-73124G>T | intron_variant | Intron 1 of 4 | ENST00000333274.11 | NP_001953.1 | ||
| EFNA5 | XM_011543250.4 | c.-6660G>T | 5_prime_UTR_variant | Exon 1 of 5 | XP_011541552.1 | |||
| EFNA5 | NM_001410773.1 | c.126-73124G>T | intron_variant | Intron 1 of 3 | NP_001397702.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| EFNA5 | ENST00000333274.11 | c.126-73124G>T | intron_variant | Intron 1 of 4 | 1 | NM_001962.3 | ENSP00000328777.6 | |||
| EFNA5 | ENST00000504941.1 | n.398-73124G>T | intron_variant | Intron 1 of 1 | 1 | |||||
| EFNA5 | ENST00000509503.1 | c.126-73124G>T | intron_variant | Intron 1 of 3 | 5 | ENSP00000426989.1 | ||||
| EFNA5 | ENST00000505499.1 | n.56+5503G>T | intron_variant | Intron 1 of 1 | 3 | 
Frequencies
GnomAD3 genomes  0.000178  AC: 27AN: 152020Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
27
AN: 
152020
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.000177  AC: 27AN: 152136Hom.:  0  Cov.: 32 AF XY:  0.000175  AC XY: 13AN XY: 74376 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
27
AN: 
152136
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
13
AN XY: 
74376
show subpopulations 
African (AFR) 
 AF: 
AC: 
27
AN: 
41474
American (AMR) 
 AF: 
AC: 
0
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10590
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68024
Other (OTH) 
 AF: 
AC: 
0
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.497 
Heterozygous variant carriers
 0 
 2 
 3 
 5 
 6 
 8 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.